Back to search
Advanced or Metastatic ER+ HER2- Breast Cancer (mBC)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced or Metastatic ER+ HER2- Breast Cancer (mBC) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced or Metastatic ER+ HER2- Breast Cancer (mBC) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study aims to evaluate the efficacy and safety of U3-1402 in participants with advanced breast cancer (ABC). Participants have to be hormone-receptor posit…
This is a first-in-human, open-label, multicenter phase 1 study to evaluate safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary…
This is a Phase 1/2 dose escalation and cohort expansion study and will assess the safety, tolerability and anti-tumor activity of ARV-471 alone and in combinat…
Phase 1b/2 open-label trial of 225Ac-DOTATATE (RYZ101) in subjects with ER+, HER2-negative unresectable or metastatic breast cancer expressing SSTRs.